FLASH SPRING SALE: 50% Off Premium Subscription >> FLASH SPRING SALE: 50% Off Premium >>
$0.136
-0.0044 (-3.12%)
At Close: May 01, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions News Profile

Range Low Price High Price Comment
30 days $0.128 $0.170 Wednesday, 1st May 2024 CYDY stock ended at $0.136. This is 3.12% less than the trading day before Tuesday, 30th Apr 2024. During the day the stock fluctuated 8.95% from a day low at $0.129 to a day high of $0.140.
90 days $0.128 $0.270
52 weeks $0.128 $0.418

Historical Cytodyn Inc prices

Date Open High Low Close Volume
May 01, 2024 $0.140 $0.140 $0.129 $0.136 1 760 500
Apr 30, 2024 $0.138 $0.150 $0.138 $0.140 536 774
Apr 29, 2024 $0.135 $0.142 $0.135 $0.138 563 115
Apr 26, 2024 $0.148 $0.148 $0.138 $0.143 2 217 125
Apr 25, 2024 $0.146 $0.150 $0.145 $0.146 420 675
Apr 24, 2024 $0.150 $0.154 $0.145 $0.149 648 615
Apr 23, 2024 $0.152 $0.157 $0.150 $0.150 423 580
Apr 22, 2024 $0.155 $0.158 $0.149 $0.150 790 017
Apr 19, 2024 $0.151 $0.155 $0.146 $0.155 662 955
Apr 18, 2024 $0.147 $0.156 $0.143 $0.151 806 934
Apr 17, 2024 $0.148 $0.148 $0.140 $0.146 700 478
Apr 16, 2024 $0.145 $0.152 $0.130 $0.148 1 479 740
Apr 15, 2024 $0.160 $0.162 $0.128 $0.145 4 669 367
Apr 12, 2024 $0.158 $0.162 $0.157 $0.157 974 823
Apr 11, 2024 $0.161 $0.162 $0.157 $0.159 1 015 193
Apr 10, 2024 $0.158 $0.163 $0.153 $0.159 1 022 869
Apr 09, 2024 $0.170 $0.170 $0.159 $0.159 1 632 515
Apr 08, 2024 $0.165 $0.170 $0.160 $0.167 1 272 815
Apr 05, 2024 $0.167 $0.167 $0.166 $0.166 888 270
Apr 04, 2024 $0.158 $0.167 $0.155 $0.160 1 078 106
Apr 03, 2024 $0.158 $0.160 $0.155 $0.160 1 461 258
Apr 02, 2024 $0.167 $0.167 $0.153 $0.156 3 192 645
Apr 01, 2024 $0.163 $0.170 $0.162 $0.164 525 006
Mar 28, 2024 $0.169 $0.169 $0.158 $0.163 2 700 825
Mar 27, 2024 $0.165 $0.170 $0.162 $0.167 1 145 965
Click to get the best stock tips daily for free!

About Cytodyn Inc

Cytodyn CytoDyn Inc. operates as a late-stage biotechnology company. The company focuses on developing treatments for multiple therapeutic indications based on leronlimab, a novel humanized monoclonal antibody targeting the CCR5 receptor. Its Leronlimab is in a class of therapeutic monoclonal antibodies designed to address unmet medical needs in the areas of human immunodeficiency virus (HIV), cancer, immunology, and novel coronavirus disease (COVID-19).... CYDY Profile

Golden Star

Ticker Date Change Price
ETSY Apr 26 1.84% $67.43
DHT Apr 24 1.24% $11.28
LPLA Apr 19 2.49% $262.59
MLI Apr 19 6.77% $52.28
PFLT Apr 18 1.07% $11.25
DOOR Apr 18 0.88% $131.39
LNG Apr 17 0.644% $156.81
FCN Apr 16 2.99% $207.62
ELV Apr 16 4.26% $506.97
ITCI Apr 05 4.92% $68.44
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT